Company: GCTS
Filing Date: 2025-04-01
Form Type: S-3
Source: 0000950170-25-048684
Chunk: 28

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-04-01
Form: S-3
Chunk 28
---
 to restricted stock units awarded under our 2011 Incentive Compensation Plan; • 902,228 shares of our Common Stock subject to restricted stock units awarded under our 2024 Incentive Compensation Plan • 26,273,653 shares of our Common Stock issuable upon exercise of outstanding warrants at a weighted-average exercise price of $11.48 per share; and • 527,397 shares of our Common Stock reserved for issuance upon the conversion of $5,273,973 aggregate principal amount of convertible notes plus the amount of accrued and unpaid interest, if any, that is payable in shares of Common Stock in connection with the conversion thereof. 3

<div align='center'>RISKFACTORS</div>

Investing in our Common Stock involves substantial risk. You should carefully consider the risk factors disclosed below as well as those contained in our most recent Annual Report on Form 10-K, which is incorporated by reference herein, as updated by our subsequent filings under the Exchange Act, and the other information contained in this prospectus before acquiring any of our common stock. These risks could have a material adverse effect on our business, results of operations or financial condition and cause the value of our common stock to decline. You could lose all or part of your investment.

This prospectus also contains or incorporates by reference forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of certain factors, including the risks faced by us described or incorporated by reference in this prospectus. See “Cautionary Note Regarding Forward-Looking Statements.”

<div align='center'>Risks Related to our Common Stock and the Offering</div>

Our management will have broad discretion as to the use of proceeds from this offering and we may not use the proceeds effectively.

Our management will have broad discretion in the application of the net proceeds from this offering, if any, and could spend the proceeds in ways that do not improve our results of operations or enhance the value of our Common Stock. You will be relying on the judgment of our management concerning these uses and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being used appropriately. The failure of our management to apply these funds effectively could result in unfavorable returns and uncertainty about our prospects, each of which could cause the price of our Common Stock to decline.

There may be future dilution of our Common Stock as a result of future sales of our Common Stock, which could adversely impact our stock price